title: An automated ELISA using recombinant antigens for serologic diagnosis of B virus infections in macaques.
abstract: B virus (Macacine herpesvirus 1) occurs naturally in macaques and can cause lethal zoonotic infections in humans. Detection of B virus (BV) antibodies in macaques is essential for the development of SPF breeding colonies and for diagnosing infection in macaques that are involved in human exposures. Traditionally, BV infections are monitored for presence of antibodies by ELISA (a screening assay) and western blot analysis (WBA; a confirmatory test). Both tests use lysates of infected cells as antigens. Because WBA often fails to confirm the presence of low-titer serum antibodies detected by ELISA, we examined a recombinant-based ELISA as a potential alternative confirmatory test. We compared a high-throughput ELISA using 384-well plates for simultaneous antibody screening against 4 BV-related, recombinant proteins with the standard ELISA and WBA. The recombinant ELISA results confirmed more ELISA-positive sera than did WBA. The superiority of the recombinant ELISA over WBA was particularly prominent for sera with low (<500 ELISA units) antibody titers. Among low-titer sera, the relative sensitivity of the recombinant ELISA ranged from 36.7% to 45.0% as compared with 3.3% to 10.0% for WBA. In addition, the screening and confirmatory assays can be run simultaneously, providing results more rapidly. We conclude that the recombinant ELISA is an effective replacement for WBA as a confirmatory assay for the evaluation of macaque serum antibodies to BV.
authors.affiliation: Viral Immunology Center, Georgia State University, Atlanta, GA, USA. dkatz@gsu.edu
authors.forename: David
authors.initials: D
authors.lastname: Katz
authors.forename: Wei
authors.initials: W
authors.lastname: Shi
authors.forename: Irina
authors.initials: I
authors.lastname: Patrusheva
authors.forename: Ludmila
authors.initials: L
authors.lastname: Perelygina
authors.forename: Manjunath S
authors.initials: MS
authors.lastname: Gowda
authors.forename: Peter W
authors.initials: PW
authors.lastname: Krug
authors.forename: Chadi N
authors.initials: CN
authors.lastname: Filfili
authors.forename: John A
authors.initials: JA
authors.lastname: Ward
authors.forename: Julia K
authors.initials: JK
authors.lastname: Hilliard
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D015153:Blotting, Western / Q000662:veterinary; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods / Q000662:veterinary*; D006566:Herpesviridae Infections / Q000175:diagnosis / Q000662:veterinary*; D006568:Herpesvirus 1, Cercopithecine / Q000276:immunology*; D008253:Macaca mulatta; D008992:Monkey Diseases / Q000175:diagnosis* / Q000821:virology*; D011994:Recombinant Proteins / Q000276:immunology; D012698:Serologic Tests / Q000379:methods / Q000662:veterinary*
chemical_list: D000956:Antigens, Viral; D011994:Recombinant Proteins
references.citation: J Clin Microbiol. 1988 Apr;26(4):662-7
references.pmid: 2835389
references.citation: J Clin Microbiol. 2008 Jan;46(1):56-61
references.pmid: 17989200
references.citation: J Virol Methods. 1986 Sep;14(2):99-109
references.pmid: 3021805
references.citation: J Virol Methods. 2001 Aug;96(2):157-70
references.pmid: 11445146
references.citation: J Gen Virol. 1984 Oct;65 ( Pt 10):1839-43
references.pmid: 6387042
references.citation: J Clin Microbiol. 2005 Feb;43(2):620-8
references.pmid: 15695655
references.citation: Clin Diagn Lab Immunol. 2001 Nov;8(6):1150-5
references.pmid: 11687456
references.citation: Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S30-8
references.pmid: 21548185
references.citation: Comp Med. 2012 Dec;62(6):516-26
references.pmid: 23561886
references.citation: J Clin Microbiol. 2001 Sep;39(9):3025-30
references.pmid: 11526123
references.citation: J Virol Methods. 1991 Sep;34(1):57-70
references.pmid: 1659581
references.citation: J Clin Microbiol. 2002 Jul;40(7):2526-32
references.pmid: 12089274
references.citation: Contemp Top Lab Anim Sci. 2002 Jul;41(4):36-41
references.pmid: 12109895
references.citation: Arch Virol. 2002 Nov;147(11):2057-73
references.pmid: 12417944
references.citation: J Clin Microbiol. 2002 Oct;40(10):3635-40
references.pmid: 12354858
references.citation: J Clin Microbiol. 1999 Aug;37(8):2709-14
references.pmid: 10405428
references.citation: J Clin Lab Anal. 2000;14(1):13-6
references.pmid: 10645979
references.citation: Clin Vaccine Immunol. 2009 Mar;16(3):366-71
references.pmid: 19129469
references.citation: Clin Microbiol Rev. 1999 Jan;12(1):1-8
references.pmid: 9880471
references.citation: J Med Microbiol. 2008 Sep;57(Pt 9):1087-1093
references.pmid: 18719177
references.citation: Clin Vaccine Immunol. 2006 Apr;13(4):444-51
references.pmid: 16603611
references.citation: J Clin Microbiol. 1986 Apr;23(4):725-30
references.pmid: 2422204
references.citation: Arch Virol. 2002 May;147(5):929-41
references.pmid: 12021865
references.citation: J Med Virol. 1990 Jan;30(1):45-9
references.pmid: 2154542
references.citation: Comp Med. 2008 Feb;58(1):11-21
references.pmid: 19793452
references.citation: J Clin Microbiol. 1999 Feb;37(2):376-9
references.pmid: 9889222
references.citation: J Virol Methods. 2011 Dec;178(1-2):143-52
references.pmid: 21945221
references.citation: Clin Vaccine Immunol. 2009 Aug;16(8):1236-46
references.pmid: 19553553
references.citation: Clin Vaccine Immunol. 2010 Mar;17(3):335-41
references.pmid: 20089793
references.citation: JAMA. 2006 Mar 8;295(10):1152-60
references.pmid: 16522836
references.citation: J Med Virol. 1985 Jun;16(2):147-62
references.pmid: 2409225